NO20082365L - Ny metode for fremstilling av 5-amino-3H-tiazolo[4,5-D]pyrimidin-2-on - Google Patents
Ny metode for fremstilling av 5-amino-3H-tiazolo[4,5-D]pyrimidin-2-onInfo
- Publication number
- NO20082365L NO20082365L NO20082365A NO20082365A NO20082365L NO 20082365 L NO20082365 L NO 20082365L NO 20082365 A NO20082365 A NO 20082365A NO 20082365 A NO20082365 A NO 20082365A NO 20082365 L NO20082365 L NO 20082365L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- thiazolo
- pyrimidin
- amino
- new method
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Foreliggende oppfinnelse angår en fremgangsmåte for fremstilling av tittelforbindelsen, 5-amino-3H-tiazolo[4,5-d]pyrimidin-2-on, som er et anvendelig mellomprodukt ved fremstilling av visse tiazolo[4,5-d]pyrimidin-nukleosider, som kan ha nytte som immunmodulerende midler.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73805505P | 2005-11-21 | 2005-11-21 | |
PCT/US2006/061111 WO2007062355A2 (en) | 2005-11-21 | 2006-11-20 | PROCESS FOR THE PREPARATION OF 5-AMINO-3H- THIAZOLO [4 , 5 -d] PYRIMIDIN- 2 -ONE |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20082365L true NO20082365L (no) | 2008-08-18 |
Family
ID=37908057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20082365A NO20082365L (no) | 2005-11-21 | 2008-05-26 | Ny metode for fremstilling av 5-amino-3H-tiazolo[4,5-D]pyrimidin-2-on |
Country Status (18)
Country | Link |
---|---|
US (1) | US7781581B2 (no) |
EP (1) | EP1973920B1 (no) |
JP (1) | JP5117391B2 (no) |
KR (1) | KR20080090400A (no) |
CN (1) | CN101365705A (no) |
AR (1) | AR058210A1 (no) |
AT (1) | ATE474842T1 (no) |
AU (1) | AU2006318260B2 (no) |
BR (1) | BRPI0618789A2 (no) |
CA (1) | CA2630463C (no) |
DE (1) | DE602006015700D1 (no) |
EA (1) | EA200801404A1 (no) |
ES (1) | ES2345904T3 (no) |
IL (1) | IL191568A0 (no) |
NO (1) | NO20082365L (no) |
SG (1) | SG152296A1 (no) |
TW (1) | TWI383987B (no) |
WO (1) | WO2007062355A2 (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE496924T1 (de) | 2006-06-22 | 2011-02-15 | Anadys Pharmaceuticals Inc | Prodrugs von 5-amino-3-(3'-deoxy-beta-d- ribofuranosyl)-thiazolä4,5-düpyrimidin-2,7-dion |
JPWO2012102366A1 (ja) * | 2011-01-28 | 2014-06-30 | 日本たばこ産業株式会社 | 新規ピペラジン化合物の製造方法 |
CN103012284A (zh) * | 2012-12-26 | 2013-04-03 | 无锡捷化医药科技有限公司 | 一种2-氨基-5-溴嘧啶类化合物的制备方法 |
JP6817217B2 (ja) | 2014-12-08 | 2021-01-20 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | ウイルス感染症の治療および予防のための3−置換された5−アミノ−6H−チアゾロ[4,5−d]ピリミジン−2,7−ジオン化合物 |
JP7201598B2 (ja) | 2017-01-06 | 2023-01-10 | エフ.ホフマン-ラ ロシュ アーゲー | 3位置換5-アミノ-6H-チアゾロ[4,5-d]ピリミジン-2,7-ジオン化合物の製造法 |
CN111635368B (zh) * | 2020-06-12 | 2021-06-29 | 东莞市东阳光仿制药研发有限公司 | 一种胺化合物的制备方法 |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4643992A (en) | 1982-11-09 | 1987-02-17 | Scripps Clinic And Research Foundation | Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives |
US4539205A (en) | 1982-11-09 | 1985-09-03 | Scripps Clinic And Research Foundation | Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives |
US5166141A (en) | 1983-11-01 | 1992-11-24 | Scripps Clinic And Research Foundation | Immunostimulating 7-deaza-7-oxa- and 7-deaza-7-oxo-analogs of 8-substituted-guanine-9-(1'-beta-D-aldoglycosidyl) derivatives and methods of treating test animals |
US4746651A (en) | 1983-11-01 | 1988-05-24 | Scripps Clinic And Research Foundation | Antimicrobial chemotherapeutic potentiation using substituted nucleoside derivatives |
US5011828A (en) | 1985-11-15 | 1991-04-30 | Michael Goodman | Immunostimulating guanine derivatives, compositions and methods |
GB8712745D0 (en) | 1987-05-30 | 1987-07-01 | Wellcome Found | Antiviral compounds |
US5041426A (en) * | 1987-12-21 | 1991-08-20 | Brigham Young University | Immune system enhancing 3-β-d-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and nucleotides |
US4880784A (en) | 1987-12-21 | 1989-11-14 | Brigham Young University | Antiviral methods utilizing ribofuranosylthiazolo[4,5-d]pyrimdine derivatives |
US5041542A (en) | 1988-06-03 | 1991-08-20 | Nucleic Acid Research Institute | Substituted pyrimido[5,4-d]pyrimidine nucleosides |
GB9015914D0 (en) | 1990-07-19 | 1990-09-05 | Wellcome Found | Heterocyclic compounds |
US5248672A (en) | 1990-11-01 | 1993-09-28 | The Regents Of The University Of Michigan | Polysubstituted benzimidazole nucleosides as antiviral agents |
GB9105899D0 (en) | 1991-03-20 | 1991-05-08 | Wellcome Found | Therapeutic nucleosides |
WO1994007904A1 (en) | 1992-10-01 | 1994-04-14 | Mcneilab, Inc. | Derivatives of 7,8-disubstituted guanosines |
GB9301000D0 (en) | 1993-01-20 | 1993-03-10 | Glaxo Group Ltd | Chemical compounds |
US5395937A (en) | 1993-01-29 | 1995-03-07 | Minnesota Mining And Manufacturing Company | Process for preparing quinoline amines |
US5446045A (en) | 1993-12-20 | 1995-08-29 | Revankar; Ganapathi R. | Antiviral guanine analogs |
US5994321A (en) | 1993-12-20 | 1999-11-30 | Aronex Pharmaceuticals, Inc. | Antiviral guanine analogs |
US5496816A (en) * | 1994-03-14 | 1996-03-05 | Merck & Co., Inc. | Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
NZ329798A (en) | 1996-07-03 | 1999-04-29 | Japan Energy Corp | Purine derivatives their tautomers and salts thereof and interferon secretion inducers, antiviral agents and anticancer drugs containing the same |
JP2001524936A (ja) | 1996-10-16 | 2001-12-04 | アイ・シー・エヌ・フアーマシユーテイカルズ・インコーポレイテツド | プリンl―ヌクレオシド類およびその用途 |
US6509320B1 (en) | 1996-10-16 | 2003-01-21 | Icn Pharmaceuticals, Inc. | Purine L-nucleosides, analogs and uses thereof |
JP4391592B2 (ja) | 1996-10-25 | 2009-12-24 | スリーエム カンパニー | Th2介在性および関連疾患治療のための免疫応答修飾化合物 |
EP1035123B1 (en) | 1997-11-28 | 2003-08-20 | Sumitomo Pharmaceuticals Company, Limited | Novel heterocyclic compounds |
TW572758B (en) | 1997-12-22 | 2004-01-21 | Sumitomo Pharma | Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives |
AU3213699A (en) * | 1998-04-03 | 1999-10-25 | Du Pont Pharmaceuticals Company | Thiazolo(4,5-d)pyrimidines and pyridines as corticotropin releasing factor (CRF)antagonists |
US6444652B1 (en) | 1998-08-10 | 2002-09-03 | Novirio Pharmaceuticals Limited | β-L-2'-deoxy-nucleosides for the treatment of hepatitis B |
US6664260B2 (en) | 2000-12-08 | 2003-12-16 | 3M Innovative Properties Company | Heterocyclic ether substituted imidazoquinolines |
US6664264B2 (en) | 2000-12-08 | 2003-12-16 | 3M Innovative Properties Company | Thioether substituted imidazoquinolines |
US6545017B1 (en) | 2000-12-08 | 2003-04-08 | 3M Innovative Properties Company | Urea substituted imidazopyridines |
US6545016B1 (en) | 2000-12-08 | 2003-04-08 | 3M Innovative Properties Company | Amide substituted imidazopyridines |
US6667312B2 (en) | 2000-12-08 | 2003-12-23 | 3M Innovative Properties Company | Thioether substituted imidazoquinolines |
US20020086871A1 (en) | 2000-12-29 | 2002-07-04 | O'neill Brian Thomas | Pharmaceutical composition for the treatment of CNS and other disorders |
JP4331944B2 (ja) | 2001-04-17 | 2009-09-16 | 大日本住友製薬株式会社 | 新規アデニン誘導体 |
US7321033B2 (en) * | 2001-11-27 | 2008-01-22 | Anadys Pharmaceuticals, Inc. | 3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof |
UA79764C2 (en) | 2001-11-27 | 2007-07-25 | Anadys Pharmaceuticals Inc | 3-?-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF |
NZ536123A (en) | 2002-05-06 | 2006-09-29 | Genelabs Tech Inc | Nucleoside derivatives for treating hepatitis C virus infection |
US7196090B2 (en) * | 2002-07-25 | 2007-03-27 | Warner-Lambert Company | Kinase inhibitors |
WO2005016235A2 (en) | 2003-04-14 | 2005-02-24 | The Regents Of The University Of California | Combined use of impdh inhibitors with toll-like receptor agonists |
MXPA05013434A (es) * | 2003-06-12 | 2006-03-17 | Astellas Pharma Inc | Derivados de benzamida o sal del mismo. |
OA13310A (en) | 2003-09-05 | 2007-04-13 | Anadys Pharmaceuticals Inc | TLR7 ligands for the treatment of hepatitis C. |
JP2007527918A (ja) * | 2004-03-08 | 2007-10-04 | アムジェン インコーポレイテッド | Pparガンマ活性の治療的調節 |
JP2008516978A (ja) | 2004-10-15 | 2008-05-22 | バイエル・フアーマシユーチカルズ・コーポレーシヨン | 肥満症の処置のためのビフェニル−4−イル−カルボニルアミノ酸誘導体の製造および使用 |
SI2561872T1 (sl) * | 2004-12-17 | 2015-02-27 | Anadys Pharmaceuticals, Inc. | 3,5-disubstituirane in 3,5,7-trisubstituiran-3H-oksazolo in 3H-tiazolo(4,5-d)pirimidin-2-onske spojine in njihova predzdravila |
US7803790B2 (en) | 2005-05-09 | 2010-09-28 | Hydra Biosciences, Inc. | Compounds for modulating TRPV3 function |
ATE496924T1 (de) | 2006-06-22 | 2011-02-15 | Anadys Pharmaceuticals Inc | Prodrugs von 5-amino-3-(3'-deoxy-beta-d- ribofuranosyl)-thiazolä4,5-düpyrimidin-2,7-dion |
WO2008011406A2 (en) | 2006-07-18 | 2008-01-24 | Anadys Pharmaceuticals, Inc. | Carbonate and carbamate prodrugs of thiazolo [4,5-d] pyrimidines |
-
2006
- 2006-11-20 CA CA2630463A patent/CA2630463C/en not_active Expired - Fee Related
- 2006-11-20 AU AU2006318260A patent/AU2006318260B2/en not_active Ceased
- 2006-11-20 EA EA200801404A patent/EA200801404A1/xx unknown
- 2006-11-20 KR KR1020087014973A patent/KR20080090400A/ko not_active Application Discontinuation
- 2006-11-20 US US11/601,719 patent/US7781581B2/en not_active Expired - Fee Related
- 2006-11-20 WO PCT/US2006/061111 patent/WO2007062355A2/en active Application Filing
- 2006-11-20 JP JP2008541505A patent/JP5117391B2/ja not_active Expired - Fee Related
- 2006-11-20 SG SG200903039-6A patent/SG152296A1/en unknown
- 2006-11-20 CN CNA200680050892XA patent/CN101365705A/zh active Pending
- 2006-11-20 EP EP06846356A patent/EP1973920B1/en not_active Not-in-force
- 2006-11-20 DE DE602006015700T patent/DE602006015700D1/de active Active
- 2006-11-20 BR BRPI0618789A patent/BRPI0618789A2/pt not_active IP Right Cessation
- 2006-11-20 ES ES06846356T patent/ES2345904T3/es active Active
- 2006-11-20 TW TW095142739A patent/TWI383987B/zh not_active IP Right Cessation
- 2006-11-20 AT AT06846356T patent/ATE474842T1/de not_active IP Right Cessation
- 2006-11-21 AR ARP060105089A patent/AR058210A1/es not_active Application Discontinuation
-
2008
- 2008-05-20 IL IL191568A patent/IL191568A0/en unknown
- 2008-05-26 NO NO20082365A patent/NO20082365L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2007062355A2 (en) | 2007-05-31 |
ATE474842T1 (de) | 2010-08-15 |
AU2006318260B2 (en) | 2012-05-17 |
AR058210A1 (es) | 2008-01-23 |
AU2006318260A1 (en) | 2007-05-31 |
US20070117979A1 (en) | 2007-05-24 |
TW200736265A (en) | 2007-10-01 |
EP1973920A2 (en) | 2008-10-01 |
KR20080090400A (ko) | 2008-10-08 |
DE602006015700D1 (de) | 2010-09-02 |
JP5117391B2 (ja) | 2013-01-16 |
CN101365705A (zh) | 2009-02-11 |
ES2345904T3 (es) | 2010-10-05 |
BRPI0618789A2 (pt) | 2016-08-30 |
IL191568A0 (en) | 2008-12-29 |
CA2630463A1 (en) | 2007-05-31 |
EA200801404A1 (ru) | 2008-10-30 |
JP2009516709A (ja) | 2009-04-23 |
CA2630463C (en) | 2015-01-06 |
EP1973920B1 (en) | 2010-07-21 |
US7781581B2 (en) | 2010-08-24 |
WO2007062355A3 (en) | 2007-07-26 |
TWI383987B (zh) | 2013-02-01 |
SG152296A1 (en) | 2009-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20074093L (no) | Fremgangsmater for fremstilling av glukopyranosyl-substituerte benzyl-benzenderivater og mellomprodukter derav | |
WO2007035629A3 (en) | Process for the preparation of pyrimidinedione derivatives | |
NO345018B1 (no) | Framgangsmåte for framstilling av organofluorforbindelser i alkoholholdige løsningsmidler. | |
NO20082365L (no) | Ny metode for fremstilling av 5-amino-3H-tiazolo[4,5-D]pyrimidin-2-on | |
WO2007023110A3 (en) | P38 map kinase inhibitors and methods for using the same | |
EA200970519A1 (ru) | Полиморфы сукцината 2-[6-(3-аминопиперидин-1-ил)-3-метил-2,4-диоксо-3,4-дигидро-2h-пиримидин-1-илметил]-4-фторбензонитрил и способы их применения | |
EA200801381A1 (ru) | Производные пиримидина | |
NO20080129L (no) | Fremgangsmate for fremstilling av dihydrokinazoliner | |
CL2007003459A1 (es) | Proceso de preparacion de compuestos derivados de pirimidina; y compuesto intermediario (s)-trans-etil 3-etoxi-7-(4-(4-fluorofenil)-6-isopropil-2-(n-metilmetilsulfonamido)pirimidin-5-il)-5-hidroxihep-2,6-dienoato. | |
WO2005076990A3 (en) | Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors | |
WO2007092095A3 (en) | [4-(benzo [b] thi0phen-2-yl) pyrimidin-2yl] -amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases. | |
WO2009006389A8 (en) | Pyrimidine derivatives useful as raf kinase inhibitors | |
WO2007022459A3 (en) | Processes and intermediates | |
NO20075232L (no) | Fremgangsmate for fremstilling av pyrido[2,3-d]pyrimidin-7-on og 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1 H)-on derivater | |
WO2006087120A3 (de) | Pyrazolopyrimidine | |
WO2006072612A3 (en) | Triazolophthalazines as pde2- inhibitors | |
TW200716525A (en) | Process for preparation of sulfamide derivatives | |
GEP20135780B (en) | Novel pyrazolo [3,4-d] pyrimidine derivatives as anti-cancer agents | |
WO2007070463A3 (en) | Compositions, methods and kits for removing debris from an ocular area | |
DK1838683T3 (da) | Fremgangsmåde til fremstilling af [1,4,5]-oxadiazepinderivater | |
TW200942546A (en) | A crystalline form of (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one | |
NO20073276L (no) | Metode for fremstilling av aminoetoksybenzylalkoholer | |
EA200802248A1 (ru) | Способы применения соединений 4-амино-5-хлортиено[2,3-d]-пиримидина в качестве инсектицидов | |
NO20072551L (no) | Fremgangsmate for fremstilling av purinforbindelser | |
WO2005018627A8 (en) | Alpha-aminoamide derivatives useful as anti-inflammatory agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |